Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

4-anilidopiperidine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The steady appearance of new fentanyl analogues and the associated overdose deaths require the development of sensitive screening… Expand
2012
2012
SummarySynopsisFentanyl is a synthetic opioid with short-acting analgesic activity after intravenous or subcutaneous… Expand
  • figure 1
  • table I
  • figure 2
  • table II
  • table III
Review
2006
Review
2006
Remifentanil (Ultiva), a 4-anilidopiperidine derivative of fentanyl, is an ultra-short-acting micro-opioid receptor agonist… Expand
  • table I
  • table II
  • table III
  • table IV
  • figure 1
Review
2003
Review
2003
Remifentanil is a 4-anilidopiperidine mu-opioid analgesic which is rapidly metabolized by unspecific blood and tissue esterases… Expand
1998
1998
Fentanyl, and its structural analogs lofentanil and sufentanil, are potent analgesics used clinically in the management of pain… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Review
1995
Review
1995
  • T. Egan
  • Clinical pharmacokinetics
  • 1995
  • Corpus ID: 46733797
SummaryRemifentanil is a novel, short-acting μ-receptor opioid agonist currently in the late stages of development. A member of… Expand
Review
1991
Review
1991
The findings reviewed herein have been the results of a five-year project undertaken by Anaquest to discover new therapeutically… Expand
Highly Cited
1991
Highly Cited
1991
In an effort to discover a potent ultrashort-acting mu opioid analgetic that is capable of metabolizing to an inactive species… Expand
1979
1979
Relatively little information is available concerning the influence of conformational factors on the potent analgesic actions of… Expand
1973
1973
Abstract: In view of the potency-enhancing effect of methyl substitution of the piperidine ring of the 4-phenylpiperidine… Expand